Waxman suggests US FDA is prioritising industry goals
This article was originally published in Clinica
US Congressman Henry Waxman has written to FDA Commissioner Andrew von Eschenbach questioning how the agency sets its priorities. The clear message in the letter is that the agency is putting the needs of the device and drug industry first and not those of the American consumer. The FDA has denied the claim.